| [1] |
Kovesdy CP, Furth SL, Zoccali C, et al. Obesity and kidney disease: hidden consequences of the epidemic [J]. Kidney Int, 2017, 91(2): 260-262.
|
| [2] |
Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey[J]. Lancet, 2012, 379(9818): 815-822.
|
| [3] |
赵丽云，刘素，于冬梅，等．我国居民膳食营养状况与《中国食物与营养发展纲要(2014-2020年)》相关目标的比较分析[J]．中国食物与营养，2015，21(8): 5-7.
|
| [4] |
汪丹．本市超半数成年男性超重肥胖[N]．北京日报，2016-10-21(3)．
|
| [5] |
陶婷婷．上海学生4人中就有1个小胖墩[N]．上海科技报，2016-11-25(1)．
|
| [6] |
Stefansson VTN, Schei J, Jenssen TG, et al. Central obesity associates with renal hyperfiltration in the non-diabetic general population: a cross-sectional study[J]. BMC Nephrology, 2016, 17(1): 172-181.
|
| [7] |
He Y, Li F, Wang F, et al. The association of chronic kidney disease and waist circumference and waist-to-height ratio in Chinese urban adults[J]. Medicine, 2016, 95(25): e3769.
|
| [8] |
D′Agati VD, Chagnac A, de Vries APJ, et al. Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis[J]. Nat Rev Nephrol, 2016, 12(8): 453-471.
|
| [9] |
Danziger J, Chen K, Lee J, et al. Obesity, acute kidney injury, and mortality in critical illness [J]. Crit Care Med, 2016, 44(2): 328-334.
|
| [10] |
Akarken I, Tarhan H, Ekin RG, et al. Visceral obesity: a new risk factor for stone disease[J]. Can Urol Assoc J, 2015, 9(11-12): E795-E799.
|
| [11] |
Chow WH, Dong LM, Devesa SS. Epidemiology and risk factors for kidney cancer[J]. Nat Rev Urol, 2010, 7(5): 245-257.
|
| [12] |
Stanhope KL, Schwarz JM, Keim NL, et al. Consuming fructose-sweetened, not glucose sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans[J]. J Clin Invest, 2009, 119(5): 1322-1334.
|
| [13] |
Tappy L, Le K. Metabolic effects of fructose and the worldwide increase in obesity[J]. Physiol Rev, 2010, 90(1): 23-46.
|
| [14] |
Nakayama T, Kosugi T, Gersch M, et al. Dietary fructose causes tubulointerstitial injury in the normal rat kidney [J]. Am J Physiol Renal Physiol, 2010, 298(3): F712-F720.
|
| [15] |
高翔．果糖：不健康的"健康食品" [J]. 蜜蜂杂志，2011，(3): 35-36.
|
| [16] |
程庆砾，张建荣．心肾代谢综合征[J/CD]．中华临床医师杂志(电子版)，2013，7(6): 2297-2299.
|
| [17] |
Ali Q, Dhande I, Samuel P, et al. Angiotensin type 2 receptor null mice express reduced levels of renal angiotensin II type 2 receptor/angiotensin (1-7)/Mas receptor and exhibit greater high-fat diet-induced kidney injury [J]. J Renin-Angiotensin- Aldosterone Syst, 2016, 17(3): pii: 1470320316661871.
|
| [18] |
Patel SN, Ali Q, Hussain T. Angiotensin Ⅱ type 2-receptor agonist C21 reduces proteinuria and oxidative stress in kidney of high-salt-fed obese Zucker rats [J]. Hypertension, 2016, 67(5): 906-915.
|
| [19] |
Mascali A, Franzese O, Nisticò S, et al. Obesity and kidney disease: beyond the hyperfiltration [J]. Int J Immunopathol Pharmacol, 2016, 29(3): 354-363.
|
| [20] |
Li K, Zou J, Ye Z, et al. Effects of bariatric surgery on renal function in obese patients: a systematic review and meta-analysis [J]. PLoS One, 2016, 11(10): e0163907.
|
| [21] |
Fernandes FAM, Carvalho GL, Lima DL, et al. Intragastric balloon for overweight patients [J]. J Soc Laparoendoscopic Surg, 2016, 20(1): e2015.00107.
|
| [22] |
MacLaughlin HL, Macdougall IC, Hall WL, et al. Does intragastric balloon treatment for obesity in chronic kidney disease heighten acute kidney injury risk? [J]. Am J Nephrol, 2016, 44(6): 411-418.
|